The presentation will go over how best to diagnose, assess the severity and activity of, and how best to manage thyroid eye disease, with the latest update on the treatment modalities including teprotumumab.
- Physician (fellow/resident)
- Ophthalmic photographers
- Medical Students
Participants who engage in this educational intervention will be able to:
- Diagnose thyroid eye disease
- Distinguish the severity and activity of thyroid eye disease
- Evaluate how to manage thyroid eye disease, including using teprotumumab
In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
- Sang Hong, MD
- William J. Wirostko, MD
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.